Prostate Cancer | Proceedings From a Live Event Held in Conjunction with the 2022 Genitourinary Cancers Symposium

Featuring perspectives from Drs Neeraj Agarwal, Himisha Beltran, Fred Saad and A Oliver Sartor, moderated by Dr Alan Bryce, including the following topics: Introduction (0:00) Optimal Use of Hormonal Therapy in Nonmetastatic Prostate Cancer (PC) and Metastatic Hormone-Sensitive Disease — Fred Saad, MD (4:18) Selection and Sequencing of Therapy for Patients with Metastatic CRPC (mCRPC) — A Oliver Sartor, MD (29:57) Integration of PARP Inhibitors into the Current Management of mCRPC — Himisha Beltran, MD (53:42) Available Data with, Ongoing Investigation of and Potential Future Role of PARP Inhibitor-Based Combinations — Alan H Bryce, MD (1:18:49) Novel Investigational Strategies for Patients with PC — Neeraj Agarwal, MD (1:44:48) CME information and select publications